Glycorex Transplantation publ AB is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. As of December 31, 2011, Glycosorb-ABO was used in 103 transplantation centers in 22 countries. As of December 31, 2011, the Company had four wholly owned subsidiaries, namely Glycoprobe AB, Glycorex Transplantation, Glycorex UMC AB and Glycorex UBP AB.

• Revenue in SEK (TTM)31.03m
• Net income in SEK-27.83m
• Incorporated1995
• Employees15.00

• Location
  Glycorex Transplantation AB (publ)Scheelevagen 27LUND 223 63SwedenSWE
• Phone+46 462865230
• Fax+46 462865239
• Websitehttps://glycorex.com/